Chemoinformaics analysis of Hexatriacontanoic acid
| Molecular Weight | 536.97 | nRot | 34 |
| Heavy Atom Molecular Weight | 464.394 | nRig | 21 |
| Exact Molecular Weight | 536.553 | nRing | 0 |
| Solubility: LogS | -3.071 | nHRing | 0 |
| Solubility: LogP | 2.977 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 110 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 38 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 72 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 36 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 109.733 |
| nHD | 1 | BPOL | 73.0989 |
| QED | 0.827 |
| Synth | 3.968 |
| Natural Product Likeliness | 1 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.079 |
| Pgp-sub | 0.471 |
| HIA | 0.004 |
| CACO-2 | -4.776 |
| MDCK | 0.0000135 |
| BBB | 0.492 |
| PPB | 0.496512 |
| VDSS | 1.419 |
| FU | 0.416275 |
| CYP1A2-inh | 0.186 |
| CYP1A2-sub | 0.916 |
| CYP2c19-inh | 0.072 |
| CYP2c19-sub | 0.906 |
| CYP2c9-inh | 0.019 |
| CYP2c9-sub | 0.196 |
| CYP2d6-inh | 0.706 |
| CYP2d6-sub | 0.889 |
| CYP3a4-inh | 0.243 |
| CYP3a4-sub | 0.896 |
| CL | 7.362 |
| T12 | 0.357 |
| hERG | 0.696 |
| Ames | 0.017 |
| ROA | 0.758 |
| SkinSen | 0.102 |
| Carcinogencity | 0.113 |
| EI | 0.016 |
| Respiratory | 0.965 |
| NR-Aromatase | 0.006 |
| Antiviral | No |
| Prediction | 0.606869 |